Intraclonal heterogeneity is a critical early event in the development of myeloma and precedes the development of clinical symptoms.
- Submitting institution
-
Institute of Cancer Research: Royal Cancer Hospital (The)
- Unit of assessment
- 1 - Clinical Medicine
- Output identifier
- 233
- Type
- D - Journal article
- DOI
-
10.1038/leu.2013.199
- Title of journal
- Leukemia
- Article number
- 2
- First page
- 384
- Volume
- 28
- Issue
- 2
- ISSN
- 1476-5551
- Open access status
- Out of scope for open access requirements
- Month of publication
- February
- Year of publication
- 2014
- URL
-
-
- Supplementary information
-
https://www.nature.com/articles/leu2013199#Sec7
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
17
- Research group(s)
-
-
- Citation count
- 160
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- -
- Non-English
- No
- English abstract
- -